FDA Inspection 1246171 — PolyPeptide Laboratories, Inc.

PolyPeptide Laboratories, Inc. — FEI 1000519239

The FDA completed an inspection of PolyPeptide Laboratories, Inc. on May 10, 2024 in Torrance, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 10, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)